Good News | EClinCloud Named to 2023 Future Healthcare Top 100 - China Innovative Digital Healthcare Top 100 List

The 7th Future Healthcare Top 100 Conference in 2023, themed "Beyond East and West," was successfully held in Shanghai from May 5 to 7, and the 2023 Future Healthcare Top 100 list was released at the Top 100 Awards Dinner on the evening of May 6.
EClinCloud was named to the China Innovative Digital Healthcare List (Top 100).
Founded in 2015, the Future Healthcare 100 list is China's first innovative healthcare ranking for unlisted companies launched by VB100, VCBeat, and DanKe Research Institute,
and aims to select Chinese healthcare innovators who truly represent the future of healthcare, identify the core forces of China's future healthcare industry, and drive innovation and transformation across the healthcare sector.
Being named to the China Innovative Healthcare Services Top 100,
fully demonstrates that EClinCloud's innovative R&D capabilities have been recognized by industry media and investors.
Since its founding in 2020, EClinCloud has remained committed to "technological innovation to bring effective treatments to patients" and has focused deeply on the digital healthcare field. Currently, EClinCloud's products and services cover more than 10 countries and regions worldwide, the number of projects on its platform has exceeded 100, and it has successfully supported multiple clinical trial projects in passing inspections by the National Medical Products Administration (NMPA).
In the future, EClinCloud will stay true to its founding purpose and, relying on its integrated clinical evidence support SaaS cloud platform, continue to innovate and create more intelligent digital healthcare products, hoping to empower clinical research through technology and help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.
About EClinCloud
EClinCloud is a technology company focused on clinical R&D that provides an integrated, interoperable, all-in-one clinical trial cloud platform (including eCOA, CTMS, eTMF, EDC, RTSM, and various other technology products, as well as scale management, linguistic validation, rater training, data quality analysis, and other solutions), along with clinical trial endpoint assessment technologies across different therapeutic areas (including oncology, central nervous system, and ophthalmology, among others). By combining cutting-edge technology with life data, it is building a globally leading "patient-centered" SaaS cloud platform for clinical evidence support to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the launch of drugs/devices, and benefit countless patients.


